Raptor Pharmaceuticals (RPTP) +5% AH after announcing FDA acceptance of its New Drug Application...

|About: Raptor Pharmaceutical Corp. (RPTP)|By:, SA News Editor

Raptor Pharmaceuticals (RPTP) +5% AH after announcing FDA acceptance of its New Drug Application for RP103 for the potential treatment of nephropathic cystinosis.